OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Research in Cardiology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry	79
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial	70
Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort	58
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial	57
Prognostic value of high-sensitivity cardiac troponin I after isolated non-CABG cardiac surgery	48
Heart failure burden and care among cardiology inpatients: insights from the Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study	48
HI-PLUS: design of a cluster-randomized trial evaluating structured case management with telemonitoring to improve quality of life in heart failure	45
Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysis	45
Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry	45
10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic	43
Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy	39
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry	37
Perioperative atrial fibrillation after non-cardiac surgery — A narrative review	37
Clinical characteristics and etiology-specific outcome in pediatric hypertrophic cardiomyopathy	37
Simultaneous transcatheter valve-in-valve replacement of severely degenerated bioprosthetic aortic and mitral prostheses	36
Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography	33
Association of daily physical activity with pulmonary artery pressure in HFpEF and HFmrEF NYHA class III patients: a pilot trial—feasibility and first results	32
Rebuttal to: “Comment on the CORRECT RADIAL trial: considerations on methodology and interpretation.“ (CRCD-D-26–00099)	31
Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy	30
Collagen type I degradation peptide as a predictive biomarker for mortality in ST-elevated myocardial infarction	30
Venting during venoarterial extracorporeal membrane oxygenation	28
Correlation of greyzone fibrosis compared to troponin T and late gadolinium enhancement with survival and ejection fraction in patients after acute myocardial infarction	28
Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarction	27
Protective effect of vaccination on the risk of cardiovascular disease after SARS-CoV-2 infection	27
Efficacy of coronary sinus reducer in patients with refractory angina and chronic total occlusion	26

Heterogeneity of outcomes within diabetic patients with atrial fibrillation on edoxaban: a sub-analysis from the ETNA-AF Europe registry	25
Appointment as Editor-in-Chief of Clinical Research in Cardiology—goals and vision	25
The effect of a smaller spacer in the PASCAL Ace on residual mitral valve orifice area	25
Antithrombotic strategy following valve-in-valve transcatheter aortic valve replacement. A German Statutory Health Claims data analysis	25